![](/img/cover-not-exists.png)
Parsaclisib Is a Next-Generation PI3Kδ Inhibitor With Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy
Shin, Niu, Stubbs, Matthew, Koblish, Holly, Yue, Eddy W., Soloviev, Maxim, Douty, Brent, He Wang, Kathy, Wang, Qian, Gao, Mingming, Feldman, Patricia, Yang, Gengjie, Hall, Leslie, Hansbury, Michael, OJournal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.120.265538
Date:
April, 2020
File:
PDF, 832 KB
2020